Metoclopramide (HCl)
Metoclopramide (HCl) Information
Find all the information of Metoclopramide (HCl) medicine and drugs available in Pakistan. Read the pricing, side effects, usage, instructions and dosage of Metoclopramide (HCl) by .
Metoclopramide (HCl)
medicine,pricing, side effects of Metoclopramide (HCl) medicine by company and complete information of medicines in pakistan here on this page including all packings, MG, dosage information. This list includes medicines and drugs over every region of Pakistan like Karachi, Lahore, Islamabad, Faisalabad, Rawalpindi, Multan, Peshawar, Quetta and other cities of Pakistan.About Metoclopramide (HCl)
Metoclopramide (HCl) is antiemetic with dopamine antagonist action in brain and peripheral effect on gastro-intestinal tract where it stimulates motility to improve gastric emptying and intestinal transit. Metoclopramide (HCl) is used to treat nausea, and vomiting of most causesand as an adjunct to X-ray examination of the gut. Metoclopramide (HCl) is given both orally and parentrally.
Indications
Metoclopramide (HCl) is primarily indicated in conditions like Delayed gastric emptying, Diagnostic procedures, Flatulence, Gastritis, GI motality disorder, Heart burn, Hiccup in palliative care, Migraine, Nausea and vomiting, Nausea and vomiting (chemotherapy induced), Reflux oesophagitis, and can also be given in adjunctive therapy as an alternative drug of choice in Defective lactation, Hiccup due to gastric distension in palliative care, Postural hypotension, Psychosis.
Contraindication
Metoclopramide (HCl) is contraindicated in conditions like Parkinsonism,Phaeochromocytoma,Pyloric stenosis,Dystonia.
Side Effects
The severe or irreversible adverse effects of Metoclopramide (HCl), which give rise to further complications include Tardive dyskinesia, Parkinsonism, Acute dystonia, Acute porphyria, Acute dyskinesia, Extrapyramidal reactions.The signs and symptoms that are produced after the acute overdosage of Metoclopramide (HCl) include Tachycardia, Drowsiness, Dystonia.The symptomatic adverse reactions produced by Metoclopramide (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Diarrhea, Akathisia, Skin rash, Impotence, Hypotension, Gynecomastia, Galactorrhea, Hypertension, Increase in heart rate, Hyperprolactinemia, Mental disturbances, neuroleptic disorder.
Warnings
Patient should observe caution while driving or performing other tasks requiring alertness because it may produce drowsiness. Metoclopramide should be used with caution in patients with previously detected breast cancer.Children, Young adults & elderly should be treated with care as they are at increased risk of extrapyramidal reactions. Care should be taken when metoclopramide is given to pateints with renal or hepatic impairment.
High Risk Groups
Drug should not be given to patients suffering from Liver Malfunction, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Dosage
Metoclopramide (HCl) Dosage for Adults
Dose | 10 to 15 mg |
Single Dose | 12 (12.5) |
Frequency | 6 hourly |
Route | PO,IV,IM |
Note: Renal dysfunction: decrease dose. |
Metoclopramide (HCl) Dosage for Neonatal
Dose | 0.1 mg/kg |
Single Dose | 0.1 (0.1) |
Frequency | 8 hourly |
Route | Intramuscular |
Dose | 0.1 mg/kg |
Single Dose | 0.1 (0.1) |
Frequency | 8 hourly |
Route | Intravenous |
Dose | 0.1 mg/kg |
Single Dose | 0.1 (0.1) |
Frequency | 8 hourly |
Route | Oral |
Metoclopramide (HCl) Dosage for Paedriatic
Dose | 0.1 to 0.2 mg/kg |
Single Dose | 0.15 (0.15) |
Frequency | 8 hourly |
Route | Intra Muscular |
Note: - | |
Dose | 0.1 to 0.2 mg/kg |
Single Dose | 0.15 (0.15) |
Frequency | 8 hourly |
Route | Intra Venous |
Note: - | |
Dose | 0.1 to 0.2 mg/kg |
Single Dose | 0.15 (0.15) |
Frequency | 8 hourly |
Route | Oral |
Note: - |
Brands
Community Contribution
Do you know any authentic drug which is not listed here? Please let us know.